Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
Dysplastic Nevus, Health Status Unknown, Melanoma
About this trial
This is an interventional prevention trial for Dysplastic Nevus
Eligibility Criteria
Inclusion Criteria:
- At increased risk for melanoma due to a personal history of treated melanoma without current evidence of disease, a family history of melanoma in a first-degree relative, and/or having a high-risk mole phenotype (i.e., >= 50 normal moles or >= 1 abnormal mole [dysplastic nevus]).
- Access to a computer connected to the Internet.
- Not adherent to SSE recommendations (i.e., did not conduct a thorough SSE during each of the previous 3 months).
- Able to speak and read English.
- Able to provide informed consent.
Sites / Locations
- Rutgers Cancer Institute of New Jersey
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Phase I (user testing)
Phase II Group I (mySmartCheck)
Phase II Group II (standard of care)
Participants complete telephone-based usability testing of the online program. Participants complete between 1-5 user testing sessions of the mySmartCheck program (about 45-60 minutes per session) to provide feedback on acceptability, satisfaction, comprehension, and usability.
Participants are asked to complete a baseline survey. After completing the baseline survey, participants receive access to mySmartCheck program, and continue to receive standard of care. Participants are asked to complete another survey 13 weeks post-baseline.
Participants are asked to complete a baseline survey. After completing the baseline survey, participants receive standard of care. Participants are asked to complete another survey 13 weeks post-baseline.